These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The hamartomatous polyposis syndromes: a clinical and molecular review. Schreibman IR; Baker M; Amos C; McGarrity TJ Am J Gastroenterol; 2005 Feb; 100(2):476-90. PubMed ID: 15667510 [TBL] [Abstract][Full Text] [Related]
24. Surgical implications of colorectal cancer genetics. Rodriguez-Bigas MA; Chang GJ; Skibber JM Surg Oncol Clin N Am; 2006 Jan; 15(1):51-66, vi. PubMed ID: 16389150 [TBL] [Abstract][Full Text] [Related]
25. Molecular genetics and management strategies in hereditary cancer syndromes. Hanna NN; Mentzer RM J Ky Med Assoc; 2003 Mar; 101(3):100-7. PubMed ID: 12674901 [TBL] [Abstract][Full Text] [Related]
29. [Predictive molecular diagnosis and preventive surgical treatment of hereditary colorectal carcinoma: a new field of interest for surgical research]. Hahn M; Kruppa C; Pistorius S; Schackert HK Zentralbl Chir; 1999; 124(4):278-85. PubMed ID: 10355081 [TBL] [Abstract][Full Text] [Related]
31. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families. Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729 [TBL] [Abstract][Full Text] [Related]
32. Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology. Batra S; Valdimarsdottir H; McGovern M; Itzkowitz S; Brown K Am J Gastroenterol; 2002 Mar; 97(3):729-33. PubMed ID: 11922570 [TBL] [Abstract][Full Text] [Related]
33. Colorectal cancer genetics. Dunlop MG Semin Cancer Biol; 1992 Jun; 3(3):131-40. PubMed ID: 1324746 [TBL] [Abstract][Full Text] [Related]
34. [Recent notions on intestinal cancerogenesis, their implications in genetic risk screening and preventive action of non-steroid anti-inflammatory agents]. Couturier D Bull Acad Natl Med; 2002; 186(2):421-43; discussion 443-5. PubMed ID: 12145848 [TBL] [Abstract][Full Text] [Related]
35. The molecular basis of colorectal cancer. Tejpar S; Cassiman JJ; Van Cutsem E Acta Gastroenterol Belg; 2001; 64(3):249-54. PubMed ID: 11680042 [TBL] [Abstract][Full Text] [Related]
36. Colorectal cancer: genetics and screening. Postier RG; Brandt EN J Okla State Med Assoc; 1999 Jun; 92(6):261-6. PubMed ID: 10363432 [TBL] [Abstract][Full Text] [Related]
37. [Hereditary colorectal cancer]. Hindi Muñiz N; Lamarca Lete A; Feliú Batlle J Med Clin (Barc); 2012 Mar; 138(5):220-3. PubMed ID: 22093404 [TBL] [Abstract][Full Text] [Related]
38. Developing strategies for intervention/prevention trials of individuals at risk of hereditary colon cancer. Blackburn GL; Giardiello FM J Natl Cancer Inst Monogr; 1995; (17):107-10. PubMed ID: 8573441 [TBL] [Abstract][Full Text] [Related]
39. Genetic alterations in sporadic and hereditary colorectal cancer: implementations for screening and follow-up. Souglakos J Dig Dis; 2007; 25(1):9-19. PubMed ID: 17384504 [TBL] [Abstract][Full Text] [Related]